Company Search:
Advanced Search
Sponsored Links
NOVOGEN LIMITED- ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares NOVOGEN LIMITED- ADR with three other companies in this sector in the United States: Revance Therapeutics Inc (2016 sales of $300,000.00 of which 100% was Botulinum Toxin Products), Dicerna Pharmaceuticals Inc ($295,000.00 of which 100% was RNA Interference (RNAi) Therapeutics), and Intra-Cellular Therapies Inc ($330,702.00 of which 100% was Pharmaceutical).

Sales Analysis.
  Stock Performance Chart for NOVOGEN LIMITED- ADR
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): .88
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks -11.9%  
4 Weeks -48.8%   52 Weeks -56.6%  
  Ticker: NVGN Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 294,977
(Year Ending Jan 2017).
Employees: 13
  Currency: U.S. Dollars Market Cap: 34,062,132
  Fiscal Yr Ends: June Shares Outstanding: 38,663,033
  Share Type: Ordinary Closely Held Shares: 2,366,429
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.